logo

Medical & Clinical Research

[email protected]

Cardiac Involvement as the Initial Manifestation of Diffuse Large B-Cell Lymphoma: A Case Report


Author(s): Raffaele Natale, Antonietta De Sena, Pietro Paolo Saturnino, Gianluigi Cuomo, Mariavittoria Guerra, Domenico Birra, Paolo Tirelli, Vittoria Gammaldi, Carmine Fierarossa and Vincenzo Nuzzo

Diffuse Large B-Cell Lymphoma (DLBCL) is the most common subtype of non-Hodgkin lymphoma. Cardiac involvement is uncommon and is usually secondary to disseminated disease.

Because cardiac manifestations are often nonspecific, diagnosis may be delayed despite the potentially life-threatening nature of this condition.

An 85-year-old woman presented to the Emergency Department with a 10-day history of progressive dyspnea, asthenia, and brief episodes of interscapular pain associated with presyncope. Physical examination revealed a systolic murmur and reduced breath sounds over the right lower lung field. Laboratory investigations showed elevated inflammatory and tumorrelated biomarkers, including lactate dehydrogenase and β2-microglobulin. Initial imaging excluded pulmonary embolism but identified suspicious cardiac and mediastinal lesions. Further multimodality imaging, including cardiac CT, whole-body CT, and 18F-FDG PET/CT, demonstrated extensive metabolically active disease involving the heart, mediastinum, adrenal glands, lungs, and pelvis. CT-guided biopsy of a pelvic lesion confirmed diffuse large B-cell lymphoma.

This case highlights the importance of considering secondary cardiac involvement in patients with suspected lymphoproliferative disorders and unexplained cardiac symptoms. Early recognition and prompt multidisciplinary evaluation are essential to establish the diagnosis and initiate appropriate treatment.